Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 28Melanoma 25Carcinoma, Renal Cell 22Lung Neoplasms 11Neoplasm Metastasis 10Squamous Cell Carcinoma of Head and Neck 9Neoplasms 9Colorectal Neoplasms 9Prostatic Neoplasms 8Hodgkin Disease 8Carcinoma, Transitional Cell 7Carcinoma, Hepatocellular 7Adenocarcinoma Of Esophagus 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Rectal Neoplasms 6Ovarian Neoplasms 6Pancreatic Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Nasopharyngeal Carcinoma 4Multiple Myeloma 4Endometrial Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Basal Cell 4Brain Neoplasms 4Anus Neoplasms 4Thyroid Neoplasms 3Sarcoma, Kaposi 3Recurrence 3

Interventions

Carboplatin 5Radiotherapy 4Radiation 3Radiotherapy, Conformal 2Platinum 2Pemetrexed 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Disulfides 2Cisplatin 2Bevacizumab 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1methoxyamine 1lazertinib 1durvalumab 1capmatinib 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Metformin 1Ipilimumab 1Granulocyte Colony-Stimulating Factor 1Gefitinib 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Nivolumab × 30 days × Clear all
NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

National Cancer Institute (NCI)

Phase 2/3 Suspended
427 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡